Zoll AutoPulse CPR Assist: Two Studies Present Conflicting Data
This article was originally published in The Gray Sheet
Executive Summary
Zoll Medical plans to commence a new randomized study by year end comparing its AutoPulse CPR-assist device with manual CPR to address conflicting results from two studies published in the June 14 Journal of the American Medical Association
You may also be interested in...
Zoll’s AutoPulse CPR-Assist Device Helps Resuscitate Stock, Up 24% In Q2
Zoll Medical's accelerating revenue growth, driven in part by strong sales of its AutoPulse CPR-assist device, helped fuel a 24.4% jump in the firm's stock price in the second quarter
Zoll’s AutoPulse CPR-Assist Device Helps Resuscitate Stock, Up 24% In Q2
Zoll Medical's accelerating revenue growth, driven in part by strong sales of its AutoPulse CPR-assist device, helped fuel a 24.4% jump in the firm's stock price in the second quarter
Zoll Shifts Focus From Defib To Perfusion For Cardiac Emergency Market
Forthcoming American Heart Association guidelines on emergency cardiac resuscitation will spur demand for Revivant's AutoPulse, according to Zoll Medical